Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Multiple IRS disputes involving the domestic production activities deduction
Our clients are in fields including financial services and technology
Atour Lifestyle Holdings $98 million secondary offering
We advised Atour on the transaction
National Grid $1.5 billion notes offering
The notes are due 2028 and 2033
Rockefeller Group loan and JV for Atlanta mixed-use tower
We advised Rockefeller Group on a construction loan and joint venture
Cutia Therapeutics HK$412.9 million IPO
We advised Cutia on its IPO and HKEX listing
TH International warrant exchange offer
A total of approximately 19,724,988 warrants were exchanged for shares
Tricida chapter 11 liquidation
We advised an ad hoc group of noteholders in connection with Tricida’s chapter 11 proceedings
Ocyan completes $2.7 billion cross-border restructuring
We advised Ocyan in connection with the restructuring
Akoya Biosciences $50 million follow-on offering
The stock is listed on Nasdaq
Ventas Realty $862.5 million exchangeable senior notes offering
We advised Ventas on the transaction